Federation des caisses Desjardins du Quebec’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-75
Closed -$1.65K – 3084
2025
Q4
$1.65K Hold
75
– – ﹤0.01% 2624
2025
Q3
$911 Hold
75
– – ﹤0.01% 2677
2025
Q2
$1.4K Hold
75
– – ﹤0.01% 2467
2025
Q1
$1.44K Hold
75
– – ﹤0.01% 2376
2024
Q4
$2.7K Sell
75
-75
-50% -$2.54K ﹤0.01% 2187
2024
Q3
$6.36K Hold
150
– – ﹤0.01% 2022
2024
Q2
$6.04K Hold
150
– – ﹤0.01% 1923
2024
Q1
$5.31K Hold
150
– – ﹤0.01% 1949
2023
Q4
$4.44K Buy
+150
New +$3.11K ﹤0.01% 1926
2020
Q1
– Sell
-100
Closed -$5.96K – 2364
2019
Q4
$5.96K Hold
100
– – ﹤0.01% 1991
2019
Q3
$5.9K Hold
100
– – ﹤0.01% 1930
2019
Q2
$6.45K Hold
100
– – ﹤0.01% 1941
2019
Q1
$6.35K Hold
100
– – ﹤0.01% 1769
2018
Q4
$3.8K Hold
100
– – ﹤0.01% 1823
2018
Q3
$4.28K Buy
+100
New +$3.49K ﹤0.01% 1906

Other funds holding TNDM

Federation des caisses Desjardins du Quebec's TNDM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 75 shares — an estimated $1.65K sold.

Federation des caisses Desjardins du Quebec first reported a position in TNDM in Q3 2018 and held it in 15 quarters. The position peaked at $6.45K in Q2 2019. 274 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 75 Tandem Diabetes Care shares in Q1 2026, an estimated $1.65K.
  • Federation des caisses Desjardins du Quebec first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 15 quarters.
  • Federation des caisses Desjardins du Quebec's Tandem Diabetes Care position peaked at $6.45K in Q2 2019.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.